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The regulatory mechanisms responsible for the normal erythroid steady 
state and the nature of the stimuli to erythropoiesis during periods of increased 
need have long attracted the attention of investigators. Until recently, 
however, little was known concerning the manner in which erythrocytic 
equilibrium was maintained or restored. The endocrine glands, the nervous 
system, the spleen, hypoxia of myeloid elements, and a humoral factor have 
all been implicated in the control of red blood cell production. Although the 
former three are capable of modifying erythropoiesis, they do not appear to 
constitute the primary erythropoietic stimulus, whereas the role of arterial 
oxygen tension as a basic determinant of erythropoietic activity has been 
widely confirmed by observations on experimental animals and human sub- 
jects. However, the original theory that tliis effect was due to hypoxia of 
myeloid erythrocytic precursors has been disproved. 
Carnot and Deflandre', first described a humoral erythropoietic stimulat- 
ing factor in 1906 and named this hypothetical substance hemopoietine. In 
the course of research on the regeneration of organs, these investigators dis- 
covered that the serum of bled rabbits induced erythrocytosis when adminis- 
tered to normal rabbits. In  subsequent years this intriguing concept of 
a humoral erythropoietic regulatory mechanism was responsible for a num- 
ber of attempts to confirm the existence of such an erythrocytogenic agent. 
Some of these studies were in accord with those of Carnot and Deflandre, 
but many were in disagreement. The evident discrepancies in data that 
supported this hypothesis and the negative findings of other investigators 
were such that, prior to the past few years, the humoral control of erythro- 
poietic activity was considered by most to be speculative and lacking in 
experimental support. 
Observations such as those of Reissmann3 in 1950 on the stimulation of 
erythropoiesis in parabiotic rats maintained in a normal atmosphere following 
exposure of their partners to reduced oxygen tension, the need for administer- 
ing large quantities of anemic plasma or serum in order to elicit an erythro- 
poietic response in recipient animals as pointed out by Erslev4 in 1953, and the 
demonstration of erythropoietic activity in heat-denatured anemic plasma by 
Borsook and his co-workers6 and Gordon and his associates6 in 1954 greatly 
accelerated interest in the humoral control of erythropoiesis. On the basis of 
recent studies in many laboratories,' the existence of a humoral erythropoietic 
regulatory mechanism can no longer be denied. However, the nature, site 
of production, and mode of action of the substances responsible for this effect 
have not yet been defined clearly. 
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Our observationss-10 indicate that there are both thermostable and rela- 
tively thermolabile plasma erythropoietic factors that control, respectively, 
the seemingly diverse physiological activities concerned with erythroblastic 
cellular division and the synthesis of hemoglobin. Extracts of active 
plasmas, which have been processed by boiling for 30 min., induce a singular 
type of erythropoietic response when administered to normal rats. This 
effect on erythropoiesis is characterized by erythrocytosis and reticulocytosis 
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FIGURE 1. Erythrocytosis and reticulocytosis without increase in the hemoglobin or 
hematocrit values in normal rats given 18 daily injections (Sundays excepted) of boiled 
plasma extracts from rabbits made anemic by phenylhydrazine. Each injection was 
equivalent to 2 per cent of the recipient's body weight. Average determinations of 24 ani- 
mals receiving the anemic plasma extract and a similar number of controls injected with 
Ringer's solution. 
without associated increase in the hemoglobin or hematocrit levels (FIGURE 1). 
Myeloid erythrocytic hyperplasia involving a roughly proportional increase 
in all recognizable nucleated red cell precursors is also evident in the recipients 
of these anemic plasma extracts (FIGURE 2), and it  provides, together with 
the erythrocytosis and reticulocytosis, conclusive evidence of increased 
erythropoietic activity. The newly formed cells responsible for the erythro- 
cytosis are microcytic. Their small size is apparent on stained films and 
demonstrable graphically by Price- Jones measurements.", l2 In  our opinion, 
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this type of response is the result of accelerated erythroblastic cellular division 
without augmentation in hemoglobin synthesis. 
Following discontinuation of the plasma extract injections, restoration of 
normal erythrocytic equilibrium is prompt. Recent studies12 have shown 
that this phenomenon apparently is due to impaired viability of the micro- 
cytes produced in response to this particular stimulus. Quantitative photo- 
colorimetric measurements of erythrocyte osmotic fragility in normal rats 
injected daily for two weeks with a boiled anemic plasma extract were not 
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FIGURE 2. Myeloid erythrocytic hyperplasia demonstrable a t  the end of the injection 
period in the normal rat recipients of anemic rabbit plasma extracts (see FIGURE 1). There 
was a roughly proportional increase in all recognizable nucleated red cell precursors. 
Mean cell counts of 12 animals in each group. 
by a direct cell enumeration technique employing red cell pipettes and 
hypotonic salt solutions as diluents demonstrated decreased osmotic resist- 
ance of the microcytes in the stimulated animals. Reversion to normal 
osmotic behavior accompanied the re-establishment of pretreatment erythro- 
cyte counts and Price-Jones curves when the injections of plasma extract 
were stopped. Since this fragility abnormality is not evident in situations 
involving increased activity of both humoral factors, it  cannot be assumed 
to be due to a specific action of the thermostable factor and most probably 
results from alterations in cell size and/or shape, secondary to accelerated 
erythroblastic cellular division in the absence of a comparable stimulus for 
increased hemoglobin synthesis. 
Extracts of active plasmas prepared by boiling for 30 min. or more, which 
induce erythrocytosis and reticulocytosis but fail to augment circulating 
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hemoglobin or red cell mass, are also ineffective in enhancing the uptake of 
Fe59 in erythrocytes of recipient animals. However, the response to the 
same source materials, when tested in the unmodified state or after boiling for 
only short periods of time, is characterized by an increase in both hemoglobin 
and erythrocyte values and in iron-59 incorporation in hemoglobin. The 
effect of boiling on the activity of anemic plasma, as measured by the incor- 
poration of FeSg in the hemoglobin of nitrogen mustard-treated rats, is shown 
in TABLE 1. Although activity was demonstrable by this technique in recipi- 
ents of the whole anemic plasma and of material boiled for 5 min., the 
responses to filtrates processed by boiling for longer periods were comparable 
to that of normal plasma. In  addition to these findings, the thermostable 
erythrocytogenic agent that affects the rate of cellular division is soluble in 
ether,'O whereas the relatively thermolabile substance that stimulates hemo- 
globin formation is not. 
TABLE 1
EPFECT OF BOILING O N  THE ERYTHROPOIETIC STIMULATORY ACTIVITY OF PHENYL- 
HYDRAZINE-INDUCED ANEMIC RABBIT PLASMA AS MEASURED BY THE INCORPORA- 
Mean of 4 Rats in Each Group f 1 Standard Deviation 
TION O F  FE6' I N  HEKOGLOBIN O F  NITROGEN MUSTARD-TREATED RATS 
Percentage FeSQ RBC uptake 
Materials tested 
18 hours 24 hours 42 hours l l i  
Unmodified anemic plasma.. . . . . . . . , . . 
Anemic plasma boiled 5 min.. . . . . . . . , , 
Anemic plasma boiled 10 min.,  . . . . . , . . 
Anemic plasma boiled 30 min.. . . . , , . , , 
Anemic plasma boiled 45 min.. . . , . . . . . 
Normal rabbit plasma.. . . . . . . . . . . . . . . 
16 & 2 
13 f 2 
7 & 3 
7 f 2 
5 f 2 
6 f 2 
We believe that these separable erythropoietic effects exerted by active 
plasmas are due to the presence of two factors that differ in nature and mode 
of action. One is characterized by an accelerated rate of erythroblastic 
cellular division and is related to a thermostable, ether-soluble fraction of 
plasma. The other, which involves hemoglobin synthesis, appears to be due 
to a relatively thermolabile, ether-insoluble factor. 
The possibility that processing procedures might alter the chemical and 
physiological characteristics of a single factor must be considered, but appears 
quite unlikely. Ether extracts of unmodified anemic plasma evoke responses 
in recipient rats identical to those induced by boiled filtrates of such plasmas 
or their ether-soluble fraction. Furthermore, the demonstration of micro- 
cytes with decreased osmotic resistance in the blood of patients with poly- 
cythemia Vera (PIGURE 3), a disorder associated with increased plasma 
erythropoietic a c t i ~ i t y , ~ ~  13, and the retention in ether-insoluble fractions 
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of active plasmas of an enhancing effect on the incorporation of Fe69 in 
hemoglobin provide additional evidence against such an occurrence. 
We have yet to study an active plasma, regardless of the experimental or 
clinical conditions under which it was obtained, that did not possess activity 
attributable to both humoral factors. Although their combined effects in 
normal recipients on hemoglobin synthesis and cellular division result in the 
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FIGURE 3. Erythrocyte osmotic fragilities determined by a direct cell enumeration 
technique and red cell diameter distributions (Price-Jones measurements) of a patient with 
polycythemia Vera demonstrating the presence of microcytes with decreased osmotic 
resistance similar to those observed in normal rats injected with the thermostable, ether- 
soluble erythropoietic factor. These findings persisted, as did enhanced plasma erythro- 
poietic activity, after no1 ma1 erythroid values had been attained following treatment with 
Pr2. Prior to therapy the hematocrit, hemoglobin, and erythrocyte count in this patient 
were 63.5 volumes per cent, 18.2 gm./100 ml., and 8,500,000 per cu.mm., respectively, with 
similar dctc~minations of 45.0, 15.2, and 5,555,000 at the time the posttreatment plasma 
was obtained. Control values represent the composite curves of 8 normal subjects. 
the methods used to demonstrate stimulatory activity and prepare materials 
for testing assume paramount importance in the interpretation of experi- 
mental results. Unmodified active plasmas or their extracts boiled for only 
short periods of time will yield evidence in recipient animals of altered erythro- 
poietic activity irrespective of the assay methods employed. The response 
to these materials in normal rats given 10 to 14 daily injections is charac- 
terized by augmentation in all erythroid determinations, together with 
myeloid erythrocytic hyperplasia. The presence of the relatively thermo- 
labile factor can also be detected by the short-term method that utilizes 
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the incorporation of iron-59 in hemoglobin as a means of demonstrating 
increased hemoglobin synthesis. Ether extracts of these same plasmas or 
their filtrates processed by prolonged boiling, however, contain only the 
factor that affects erythroblastic cellular division, and they do not enhance 
the formation of hemoglobin. Therefore, the differences in chemical and 
physiological attributes of the humoral erythrocytogenic agents would appear 
in many instances to explain the apparent disparity in experimental observa- 
tions that have been described by various investigators. 
The majority of our studies in regard to the chemical identities of the 
plasma erythropoietic factors have dealt with the thermostable, ether-soluble 
factor, and current information indicates that it is most probably a lipid. 
Similarities in the chemical and physical characteristics of batyl alcohol, the 
monoglycerol ether of woctadecyl alcohol, and the ether-soluble plasma 
erythropoietic factor suggested a possible relationship between these two 
substances. Batyl alcohol was isolated from bovine yellow bone marrow 
by Holmes and his associates16 in 1941, and a few reports have indicated that 
it possesses erythropoietic16 and l e ~ k o p o i e t i c ~ ~ - l ~  activity. Our observa- 
tions20 have confirmed the erythrocytic stimulatory effect of batyl alcohol, 
which was manifested in normal rats given daily injections of batyl alcohol 
in peanut oil over a period of four weeks by erythrocytosis due to micro- 
cytes with decreased osmotic resistance, reticulocytosis, and myeloid erythro- 
cytic hyperplasia without increase in their hemoglobins or hematocrits. 
Batyl alcohol is also ineffective in enhancing the incorporation of Fe69 in 
hemoglobin of recipient animals.21 On the basis of this erythrocytic response, 
which was identical in all respects demonstrable by the methods used to that 
observed following the administration of the thermostable, ether-soluble 
plasma erythropoietic factor, together with their common chemical and 
physical properties, it  is suggested that batyl alcohol, originating in yellow 
bone marrow, may be identical with or closely related to this factor, perhaps 
as precursor material. 
An increase in circulating thrombocytes has been a consistent finding in 
all animals to which we have given batyl alcohol with a prompt return to 
base line and control values when the injections are stopped.20 Although 
daily doses of 25 mg. or less of batyl alcohol used in the above experiment 
did not alter the recipients' leukocyte counts, other studiesZ1 indicate that it 
also possesses granulopoietic stimulatory activity. However, greater 
amounts apparently are necessary to evoke this response in normal rats than 
are needed to elicit erythrocyte and thrombocyte increases. 
Since certain lipid substances induce hemolysis which may be associated 
with thrombocytosis and leukocytosis, this possibility must be excluded 
before true myelopoietic stimulatory properties can be assigned to batyl 
alcohol. All of the hematological phenomena ascribed to batyl alcohol are 
compatible with a compensated hemolytic state with the exception of the 
erythrocytosis, and this could conceivably represent red cell cytoclasis with 
impaired viability of the resultant erythrocytic fragments. However, it 
would then be necessary to postulate definite augmentation in hemoglobin 
synthesis as a prerequisite for the maintenance of normal hemoglobin and 
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hematocrit values, and enhanced iron-59 incorporation in hemoglobin should 
be evident. The failure of batyl alcohol to increase erythrocyte iron-59 
uptake in recipient ratsz1 would appear to exclude hemolysis and supports 
the conclusion that this compound does exert a primary stimulatory effect 
on hematopoiesis. 
These observations on the erythropoietic, thrombopoietic, and probable 
granulopoietic activity of batyl alcohol are in accord with the theory that all 
aspects of myelopoiesis may be under the influence of humoral regulatory 
mechanisms. Since erythrocytes, thrombocytes, and granulocytes are all 
derived from the multipotential myeloid reticulum cells, a single substance or 
activator-inhibitor complex may control the formation of all these hemic 
elements. If this concept is confirmed by further investigation, the patho- 
genetic mechanisms responsible for a number of heretofore poorly understood 
hematological findings involving hyperactivity of myeloid elements en masse 
may be clarified. These include, among others, the granulocytosis and 
thrombocytosis that accompany acute blood loss and certain types of intra- 
vascular hemolysis and the increase in these hemic cells in patients with 
polycythemia Vera. 
The precise physiological and pathophysiological significance of the 
humoral erythropoietic factors is not known, but available data support 
the hypothesis that they constitute the primary erythropoietic stimulus. 
Enhanced plasma activity has been found in a number of clinical and experi- 
mental situations which, although of diverse etiologies, all with the exception 
of polycythemia Vera have hypoxia as a common denominator. Therefore, 
i t  may be inferred that elaboration of the plasma erythropoietic factors is 
probably dependent on the relationship between oxygen supply and tissue 
requirements a t  the as yet undetermined site or sites of their formation. 
Since some activity is demonstrable in the plasma of normal subjects, espe- 
cially after c~ncentration,~* 22 it may be concluded that the humoral factors 
contribute to the maintenance of the normal erythroid steady state and 
probably constitute the primary erythropoietic stimulus. 
A well-balanced equilibrium appears to exist that ensures, under normal 
conditions, an oxygen-carrying capacity of the blood commensurate with 
cellular needs. Apparently this humoral regulatory mechanism is capable of 
responding to even minor changes in the dynamic relationship between 
oxygen supply and metabolic requirements. Erythropoietic activity thereby 
is altered accordingly, and equilibrium is re-established a t  the same or a 
different level, as the situation warrants. 
The plasma factors are probably involved to some extent in all anemias 
irrespective of their basic cause, but since erythropoiesis is dependent on a 
number of things, certain deficiencies or abnormalities of myeloid elements 
may alter the production of red cells regardless of the integrity of the humoral 
regulatory mechanism. Enhanced plasma erythropoietic activity has been 
demonstrated in experimental animals and human subjects with both hemor- 
rhagic and hemolytic anemias and undoubtedly is responsible for the myeloid 
erythrocytic hyperplasia that accompanies increased removal of red cells 
from the circulation. Since there is no associated defect of the myeloid 
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reticulum, the marrow responds to this humoral stimulus by increasing the 
production of erythrocytes. Anemia occurs only when erythrocytogenesis 
fails to keep pace with the peripheral loss. Therefore, it is apparent that 
the anemias due to increased removal of red cells from the peripheral circula- 
tion are intimately related to plasma erythropoietic stimulatory activity. 
Although the humoral agents per se are not of pathogenetic significance in 
these anemic states, their increased elaboration would appear vital for the 
restoration of normal values and in the case of persistent hemorrhage or 
hemolysis equally indispensable to temper the severity of the anemic hypoxia. 
It is possible that some failure or defect in the humoral regulatory control 
of erythropoiesis may be responsible, a t  least in part, for the “aplastic 
crises” that have been described in some types of hemolytic disease; this 
subject needs further study. 
The pathophysiological activity of the plasma factors in the anemias due to 
defective erythrogenesis is more speculative, but experimental observations 
support certain conclusions. The stimulatory effect of erythropoietic factors 
presupposes adequate amounts of the various erythrocytic constituents 
together with an intact myeloid reticulum. It is evident that a normal 
marrow response is otherwise precluded. Studies on the effect of total body 
X irradiation on plasma erythropoietic activity indicate that hematopoietic 
elements are not involved in the elaboration of the factors and that a regenera- 
tive marrow is not a prerequisite for their formation.23 Plasma extracts 
from normal and irradiated rabbits rendered anemic by phenylhydrazine 
and from those with anemia secondary to irradiation alone were each effective 
in stimulating erythropoiesis in normal rats. It follows that enhanced 
plasma activity secondary to anemic hypoxia should be demonstrable in the 
anemias that result from specific deficiency states or injury to myeloid ele- 
ments of known cause. These conditions would include deficiencies of sub- 
stances such as vitamin Blz or iron; a reduction in myeloid erythrocytic 
precursors by physical or chemical means, displacement by foreign cells, or 
diversion of growth potential by leukemic transformation; and the hereditary 
hemoglobinopathies. Although the number of patients studied is as yet 
small, increased activity has been found in each of these disorders. How- 
ever, the existent myeloid deficiency or defect prevents a normal marrow 
response to the humoral stimulus. 
It can be assumed that the plasma erythropoietic factors are not involved 
in the actual production of the depressed erythroid values in these clearly 
defined anemias. Nevertheless, their presence is probably essential for the 
continued attempt on the part of the marrow to produce some erythrocytes, 
and they probably represent the mechanism by which normal erthyrocytic 
equilibrium is restored if the basic deficiency or defect can be corrected. 
The possibility exists, however, that some abnormality in the humoral 
erythropoietic regulatory mechanism involving impaired formation of the 
plasma factors, defective utilization, or both, may be of pathogenetic impor- 
tance in certain other anemias of questionable or unknown cause. Progress 
in this regard has been slow because of the difficulties associated with measur- 
ing relative degrees of activity. 
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Polycythemia vera and secondary polycythemia are the hematological 
disorders that, except for time factors, most closely simulate the imbalance 
in erythrocytic equilibrium induced in normal rats by the administration of 
the plasma factors. Enhanced plasma erythropoietic stimulatory activity 
is demonstrable in patients with polycythemia Vera and secondary poly- 
cythemia, and has been a consistent finding in all of the patients with these 
disorders whom we have studied. The overproduction of the plasma factors 
in patients with erythrocytosis due to decreased arterial oxygen saturation is 
not surprising in view of the well-documented relationship between hypoxia 
and erythropoietic activity. Under these conditions, the hypoxic hypoxia is 
undoubtedly the stimulus for the increased elaboration of the humoral factors 
which in turn transmit the need for augmentation of the oxygen-carrying 
capacity of the blood to the myeloid reticulum. However, depending upon 
the severity of the arterial hypoxemia, the resultant increase in erythro- 
poiesis may be insufficient to restore the normal relationship between oxygen 
supply and tissue requirements. As a consequence, the physiological regula- 
tory mechanism produces an unphysiological secondary polycythemia. 
Increased amounts of the humoral erythropoietic factors in patients with 
polycythemia Vera occur in the absence of demonstrable hypoxia. Since the 
factors are apparently not a product of hyperactive myeloid elements, the 
augmented plasma erythropoietic activity in this disorder supports the view 
that polycythemia Vera may be caused by a metabolic imbalance resulting 
in the production of excessive amounts of the plasma factors or, conversely, in 
the failure to inactivate such materials a t  rates sufficient to maintain normal 
erythrocytic equilibrium. Enhanced plasma activity should then persist in 
these patients irrespective of the institution of specific myelosuppressive 
therapy. To date, we have studied the plasma of six patients with poly- 
cythemia Vera after normal erythroid values had been achieved following 
treatment with radioactive phosphorus. Myeloid erythrocytic hyperplasia 
(TABLE 2) was evident in the normal rats injected with ether extracts of the 
plasma from each of these patients and was accompanied by erythrocytosis 
and reticulocytosis. 
Augmented amounts of both the thermostable and relatively thermolabile 
plasma factors have been demonstrated in polycythemia vera, thus explaining 
the increase in all erythroid values that these patients manifest. However, 
microcytes with decreased resistance to lysis in hypotonic media similar to 
those observed in normal rats given the thermostable plasma erythropoietic 
factor are evident in the peripheral blood of patients with polycythemia vera, 
an example of which is shown in FIGURE 3 .  Simultaneous osmotic fragility 
measurements by a quantitative photocolorimetric method in these patients 
have not been found to be significantly a t  variance with those of normal 
control subjects. The small cells with abnormal osmotic behavior are still 
discernible during therapeutically induced remissions (FIGURE 3 ) ,  a not 
unexpected finding in view of the persistence after treatment of enhanced 
erythropoietic activity as determined by in vitro plasma assays. Therefore, 
in contradistinction to the evenly balanced stimulatory effect of each plasma 
factor in normal and many anemic states, the humoral agent that controls 
erythroblastic cellular division appears to predominate in polycythemia vera. 
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These observations add further support to a causal relationship between the 
erythropoietic factors and polycythemia Vera and are in agreement with the 
findings of Berlin and his c o - ~ o r k e r s ~ ~  of a bimodal red cell population in 
patients with polycythemia Vera consisting of erythrocytes with a normal life 
span and a second group with a survival time of only a few days. 
TABLE 2 
AVERAGE MARROW NUCLEATED CELLS PER CUBIC MILLIMETER OF RATS RECEIVING 
ETHER EXTRACTS OF PLASMAS FROM PATIENTS WITH POLYCYTHEMIA VERA IN 
THERAPEUTIC REMISSION 
I- I I 
Granulocytic 
elements 
VARH-6738 . . . . . . . . . . . .  
VARH-8069.. . . . . . . . . . .  
UMH-852687.. . . . . . . . . .  
UMH-772026.. . . . . . . . . .  
UMH-791448.. . . . . . . . . .  
UMH-811765.. . . . . . . . .  











































AVERAGE THROMBOCYTE COUNTS (MILLIONS PER CUBIC MILLIMETER) OF RATS 
RECEIVING ETHER EXTRACTS OF PLASMAS FROM PATIENTS WITH 
Source of plasma 
POLYCYTHEMIA VERA 
Active disease 
UMH-880933. . . . . . . .  
UMH-711011. . . . . . . . .  
UMH-876961. . . . . . . . .  
UMH-811765. . . . . . . . .  
UMH-852687. . . . . . . . .  
UMH-772026. . . . . . . .  
UMH-791448. . . . . . . . .  
Normal subject. . . . . . . .  























In  view of the evidence that implicates the erythropoietic factors in the 
pathogenesis of polycythemia Vera, experiments were designed to study the 
possible existence of humoral factors that might be responsible for the 
thrombocytosis and leukocytosis so commonly associated with this disease. 
These studies are still in progress, but preliminary observations indicate that 
ether extracts of plasma from both treated and untreated patients with 
polycythemia Vera do exert a thrombocytosis-promoting effect in normal rats 
(TABLE 3 )  in addition to accelerating erythroblastic cellular division. A 
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slight but definite increase in platelets has been a consistent finding in all 
recipients given such extracts daily for two weeks, with a prompt return to 
base line values after the injections were stopped. Although the normal 
unconcentrated human plasma extract was erythropoietically inactive, it 
would appear to contain minimal thrombocytic activity when the platelet 
counts of animals given this material are compared to those of rats injected 
with equivalent amounts of Ringer’s solution. Definitive conclusions in 
regard to these observations must await additional study; however, they 
assume increased significance in the light of the apparent myelopoietic stimu- 
latory effect of batyl alcohol, the evidence linking batyl alcohol with the 
thermostable, ether-soluble erythropoietic factor, and the findings that sug- 
gest that activity attributable to the latter factor may predominate in patients 
with polycythemia Vera. To date, all attempts to detect granulopoietic 
activity in polycythemic plasma extracts have been unsuccessful, but the 
possibility of varying degrees of sensitivity of myeloid elements to such a 
stimulus cannot be excluded. 
Summary 
Our studies indicate that a t  least two humoral factors exert regulatory 
control over erythropoiesis. A thermostable, ether-soluble agent stimulates 
erythroblastic cellular division, but does not augment hemoglobin synthesis, 
which appears to be governed b y  a relatively thermolabile, ether-insoluble 
factor. 
It is suggested, on the basis of similarities in their chemical and physiologi- 
cal properties, that  the thermostable plasma erythropoietic factor and batyl 
alcohol may be the same or related compounds. 
The thrombopoietic and probable granulopoietic activity of batyl alcohol, 
in addition to its effect on erythropoiesis, support the hypothesis that all 
aspects of myelopoiesis may be under the influence of humoral regulatory 
mechanisms. Since erythrocytes, thrombocytes, and granulocytes are all 
derived from the multipotential myeloid reticulum cells, a single agent or 
activator-inhibitor complex may control the formation of all of these hemic 
elements. Batyl alcohol, originating in yellow bone marrow, may be of 
primary importance in such a system. 
Although the precise physiological and pathophysiological significance of 
the plasma erythropoietic factors is not yet known, they most probably con- 
stitute the primary erythrocytogenic stimulus. These humoral agents 
appear to contribute to the maintenance of the normal erythroid steady 
state and to be responsible for the increased erythropoietic activity in 
hypoxic and some types of anemic hypoxia. 
Observations on the erythropoietic and probable thrombopoietic activity 
of plasma from patients with polycythemia Vera indicate that the plasma 
factors are of etiological importance in this disorder. The stimulus to this 
derangement in the humoral regulatory mechanism remains unknown. 
Further study of the humoral control of myelopoiesis should aid in clarify- 
ing the pathogenesis of certain obscure anemic states and hematological 
responses. 
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